David P Ryan Selected Research

David P Ryan Research Topics

Disease

108	Neoplasms (Cancer) 01/2022 - 01/2002
37	Adenocarcinoma 11/2022 - 01/2005
34	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 01/2002
32	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2002
18	Rectal Neoplasms (Rectal Cancer) 04/2022 - 02/2004
14	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 06/2002
11	Neoplasm Metastasis (Metastasis) 11/2022 - 06/2006
11	Diarrhea 10/2020 - 01/2003
9	Fatigue 10/2020 - 04/2004
8	Anus Neoplasms (Anal Cancer) 12/2020 - 04/2003
8	Carcinoma (Carcinomatosis) 12/2020 - 02/2004
8	Cholangiocarcinoma 12/2020 - 01/2012
8	Neutropenia 10/2016 - 04/2006
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2013 - 01/2006
7	Nausea 10/2016 - 01/2003
6	Carcinoid Tumor (Carcinoid) 01/2018 - 01/2004
6	Fibrosis (Cirrhosis) 01/2017 - 12/2013
5	Thrombocytopenia (Thrombopenia) 06/2009 - 03/2002
5	Vomiting 12/2006 - 04/2004
4	Liver Diseases (Liver Disease) 04/2020 - 12/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019 - 01/2012
4	Disease Progression 01/2019 - 02/2002
4	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2005
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2020 - 02/2008
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020 - 01/2012
3	Esophageal Neoplasms (Esophageal Cancer) 02/2019 - 03/2002
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2003
3	Febrile Neutropenia 10/2016 - 01/2002
3	Anemia 10/2016 - 11/2005
3	Peritoneal Neoplasms 02/2015 - 09/2013
3	Hyperglycemia 11/2011 - 04/2004
3	Colonic Neoplasms (Colon Cancer) 09/2010 - 09/2002
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2020
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2021 - 12/2015
2	Exanthema (Rash) 10/2020 - 11/2011
2	Circulating Neoplastic Cells 01/2020 - 01/2017
2	Carcinogenesis 01/2019 - 03/2012
2	Alopecia (Baldness) 10/2016 - 11/2005
2	Hypoxia (Hypoxemia) 05/2015 - 11/2011

Drug/Important Bio-Agent (IBA)

23	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 02/2002
17	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 09/2005
15	Gemcitabine FDA Link 01/2020 - 01/2002
13	folfirinoxIBA 10/2022 - 01/2013
13	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2022 - 01/2003
11	Leucovorin (Folinic Acid)FDA Link 10/2022 - 01/2003
11	Capecitabine (Xeloda)FDA Link 07/2019 - 01/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2005
10	Protons (Proton)IBA 04/2020 - 08/2007
9	ErbB Receptors (EGF Receptor)IBA 02/2014 - 09/2005
8	Bevacizumab (Avastin)FDA Link 03/2015 - 02/2004
7	Pharmaceutical PreparationsIBA 10/2020 - 10/2002
7	Cetuximab (Erbitux)FDA Link 02/2014 - 05/2006
7	Tyrosine Kinase InhibitorsIBA 03/2013 - 09/2005
6	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2012
5	Biological ProductsIBA 07/2018 - 07/2006
5	Everolimus FDA Link 09/2013 - 01/2009
5	Gefitinib (Iressa)FDA Link 10/2007 - 09/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2005
4	Circulating Tumor DNAIBA 10/2021 - 12/2015
4	LigandsIBA 10/2020 - 08/2007
4	130-nm albumin-bound paclitaxelIBA 01/2020 - 12/2017
4	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019 - 04/2003
3	AntigensIBA 01/2022 - 01/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 01/2007
3	Immune Checkpoint InhibitorsIBA 11/2021 - 10/2019
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020 - 08/2007
3	Monoclonal AntibodiesIBA 10/2020 - 01/2012
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2015 - 01/2012
3	Temozolomide (Temodar)FDA LinkGeneric 09/2013 - 01/2006
3	Cisplatin (Platino)FDA LinkGeneric 01/2013 - 06/2006
3	Sunitinib (Sutent)FDA Link 02/2011 - 07/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2008 - 09/2002
3	Bortezomib (Velcade)FDA Link 05/2008 - 11/2006
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2007 - 04/2006
3	Docetaxel (Taxotere)FDA Link 07/2006 - 01/2002
3	Thalidomide (Thalomid)FDA Link 02/2006 - 06/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2004 - 03/2002
2	NucleosidesIBA 01/2022 - 11/2003
2	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2015 - 11/2011
2	ProdrugsIBA 05/2015 - 01/2003

Therapy/Procedure

54	Therapeutics 04/2022 - 01/2002
42	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
27	Radiotherapy 11/2021 - 04/2003
20	Neoadjuvant Therapy 11/2022 - 08/2007
7	Chemoradiotherapy 01/2022 - 07/2010
6	Intravenous Infusions 07/2006 - 10/2002
5	Immunotherapy 11/2021 - 01/2005
5	Combination Drug Therapy (Combination Chemotherapy) 12/2019 - 01/2004
5	Proton Therapy 02/2019 - 01/2011
5	Adjuvant Chemotherapy 01/2018 - 01/2008
4	Hyperthermic Intraperitoneal Chemotherapy 01/2021 - 09/2013
3	Combined Modality Therapy 02/2019 - 12/2011
3	Drug Tapering 12/2011 - 01/2002
2	Precision Medicine 01/2022 - 01/2020
2	Palliative Care (Palliative Therapy) 01/2020 - 03/2017
2	Length of Stay 01/2019 - 11/2014
2	Subcutaneous Injections 12/2017 - 08/2006